Apple is researching the possibility of using new sensors in the next generation of its Apple Watch smart watch to provide continuous monitoring of dyskinesia and tremors, which could help doctors better treat Parkinson’s or Parkinson’s disease, according to a recent patent that indicates that Apple She might be looking to extend tracking capabilities in her smartwatch to include tremors associated with Parkinson’s disease.
Apple describes in the new patent a possible new medical feature in its smart watch Apple Watch and why it is needed, as she said: There are an estimated 600 thousand to one million cases of Parkinson’s disease in the United States and 60 thousand new cases are diagnosed each year, and include symptoms Tremor and dyskinesia, an uncontrollable and involuntary movement.
Apple’s patent claims that dyskinesia and tremors tend to occur when all other features of Parkinson’s are well managed through medications, and the company writes: Patients with Parkinson’s disease are usually treated with dopamine treatment to help reduce some symptoms of the disease.
Apple added : “Over time, dopamine therapy becomes less effective and begins to cause more side effects, such as dyskinesia. The quality of a patient’s life depends to a large extent on how doctors calibrate accurately to schedule medications and reduce their feasibility to reduce patient symptoms, and this is a challenge for doctors because each patient has a group Different symptoms can change and become more severe over time, and symptoms may fluctuate based on medications, food intake, sleep, stress and exercise. ”
The system uses motion sensors to monitor movement and the resulting data is analyzed on the device using the UPDRS classification scale, and Apple says: This provides multiple benefits and benefits, including benefits for both the patient and the doctor, such as providing information that tracks symptoms and intensity throughout the day, to It also provides a clinical tool for assessing patient response to treatment.
In addition to providing this data to help clinicians periodically adjust the drug, the system also helps the person wearing the watch better plan activities around symptoms patterns.
Source : appft.uspto